$35.16
+0.0300 (+0.0854%)
At Close: Jun 05, 2026
Here's What Key Metrics Tell Us About Conmed (CNMD) Q2 Earnings
09:05pm, Wednesday, 31'st Jul 2024
Although the revenue and EPS for Conmed (CNMD) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall Street es
Conmed (CNMD) Q2 Earnings Beat Estimates
07:01pm, Wednesday, 31'st Jul 2024
Conmed (CNMD) came out with quarterly earnings of $0.98 per share, beating the Zacks Consensus Estimate of $0.92 per share. This compares to earnings of $0.83 per share a year ago.
Conmed (CNMD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
11:07am, Wednesday, 24'th Jul 2024
Conmed (CNMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why You Should Retain CONMED (CNMD) Stock for Now
10:45am, Thursday, 27'th Jun 2024
CONMED (CNMD) continues to raise optimism among investors, owing to its broad product spectrum.
CONMED Corporation to Participate in a Fireside Chat at the Jefferies Global Healthcare Conference
04:05pm, Thursday, 23'rd May 2024
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that Curt R. Hartman, Chair of the Board, President, and Chief Executive Officer, and Todd W. Garner, Executive Vice Presi
CONMED Corporation Announces Quarterly Cash Dividend
04:05pm, Wednesday, 22'nd May 2024
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) announced today that its Board of Directors declared a quarterly cash dividend of $0.20 per share on May 22, 2024, payable on July 5, 2024
Follow the Whales: 3 Genius Stocks the Smart Money Is Piling Into for Triple-Digit Gains
02:08pm, Sunday, 19'th May 2024
Following the so-called “smart money” is often a wise strategy for retail investors. Most individual investors fail to outperform the broader market over the long-run.
CONMED Corporation to Present at the BofA Securities Healthcare Conference
04:05pm, Wednesday, 01'st May 2024
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that Curt R. Hartman, Chair of the Board, President, and Chief Executive Officer, Todd W. Garner, Executive Vice President
CONMED (CNMD) Q1 Earnings & Revenues Surpass Estimates
01:45pm, Thursday, 25'th Apr 2024
CONMED's (CNMD) adjusted first-quarter earnings and revenues beat estimates on the back of strong U.S. and International markets as well as supply-chain improvement.
CONMED Corporation (CNMD) Q1 2024 Earnings Call Transcript
01:16am, Thursday, 25'th Apr 2024
Call End: CONMED Corporation (NYSE:CNMD ) Q1 2024 Earnings Conference Call April 24, 2024, 16:30 PM ET Company Participants Curt Hartman - Chair, President and Chief Executive Officer Todd Garner - Ex
Conmed (CNMD) Reports Q1 Earnings: What Key Metrics Have to Say
08:01pm, Wednesday, 24'th Apr 2024
The headline numbers for Conmed (CNMD) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates
Conmed (CNMD) Surpasses Q1 Earnings and Revenue Estimates
06:16pm, Wednesday, 24'th Apr 2024
Conmed (CNMD) came out with quarterly earnings of $0.79 per share, beating the Zacks Consensus Estimate of $0.74 per share. This compares to earnings of $0.66 per share a year ago.
CONMED Corporation Promotes Patrick Beyer to Chief Operating Officer
04:05pm, Wednesday, 24'th Apr 2024
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that Patrick Beyer, President of International and Global Orthopedics, has been promoted to the newly created role of Chie
CONMED Corporation Announces First Quarter 2024 Financial Results
04:03pm, Wednesday, 24'th Apr 2024
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced financial results for the first quarter ended March 31, 2024. First Quarter 2024 Highlights Sales of $312.3 million increa
Here's Why You Should Retain CONMED (CNMD) Stock for Now
10:10am, Wednesday, 03'rd Apr 2024
CONMED (CNMD) continues to raise optimism among investors, owing to its broad product spectrum.
Sign In
Buy CNMD